Trials / Recruiting
RecruitingNCT05586867
Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Ramsay Générale de Santé · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
From a scientific point of view and for publication purposes, it therefore seems important to study the metabolism of iron and in particular to define its conditions of absorption, metabolism, elimination and storage in the body at course of advanced renal failure. The study will follow the evolution of hormones regulating iron metabolism and put into perspective their links with phosphocalcic and hepatic metabolisms as well as inflammation in hemodialysis patients. The main objective of this program is to study the evolution of hepcidin and erythroferrone levels in hemodialysis patients. These two biomarkers regulating iron metabolism are not performed routinely in dialysis centers and are not listed in the nomenclature.
Conditions
- Iron Metabolism Disorders
- Calcium Phosphate Metabolism
- Hepatic Metabolic Disorders
- Hemodialysis Complication
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood test | 15 mL of blood to follow the evolution of hepcidin and erythroferrone levels |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2026-12-01
- Completion
- 2031-12-01
- First posted
- 2022-10-19
- Last updated
- 2022-10-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05586867. Inclusion in this directory is not an endorsement.